---
title: "Repeated mRNA Vaccination Drives Clonal and Epitope Shifts in CD8+ T Cell Memory"
id: "biorxiv-11-repeated-exposure-to-a-conserved-antigen-drives-dynamic-clonal-and-epitope"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-11-repeated-exposure-to-a-conserved-antigen-drives-dynamic-clonal-and-epitope"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.12.763997v1?rss=1"
published_at: "2026-11-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Repeated mRNA Vaccination Drives Clonal and Epitope Shifts in CD8+ T Cell Memory
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-11-repeated-exposure-to-a-conserved-antigen-drives-dynamic-clonal-and-epitope
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.12.763997v1?rss=1)
- **Published At:** 2026-11-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators performed longitudinal paired α/β T cell receptor sequencing (TIRTL-seq) on serial samples from 38 healthy donors following COVID-19 **mRNA vaccination**. - The study focused on CD8+ T cell lineages showing vaccine-associated expansion, identified by their temporal kinetics. - Paired **TCR**s were grouped by sequence similarity to infer shared epitope specificity across lineages. - The team assigned epitope specificity to 1,109 clonotypes, mapping recognition to 15 distinct **SARS-CoV-2 spike** targets. - Several previously undescribed T cell responses were identified and some putative specificities were confirmed experimentally by the authors. - Longitudinal data indicated clonal succession: early or repeatedly exposed lineages shifted from low-avidity clones recognizing conserved coronavirus epitopes to higher-avidity clones specific to SARS-CoV-2–unique epitopes. - Authors argue these dynamics occur with homologous boosting and may inform vaccine strategy refinement and repertoire-based immune monitoring. - The report includes declared competing interests for several senior authors and lists multiple NIH and international funders. - The source did not report granular vaccine dosing schedules, exact sampling intervals, or other procedural specifics beyond serial sampling across donors.
## Clinical Analysis & Structured Key Points
Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession | bioRxiv Skip to main content New Results Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession View ORCID Profile Hiroyasu Aoki , Mikhail V. Pogorelyy , Philip Bradley , Cecilia Adragna , Stefan A. Schattgen , Anastasia A. Minervina , View ORCID Profile Koshlan Harlan Mayer-Blackwell , Kasi Vegesana , Zachary B. Scott , Velmurugan Balaraman , E. Kaitlynn Allen , Masahiro Kitabatake , Noriko Ouji-Sageshima , Atsushi Hara , Peng Xu , Chihiro Motozono , Kouji Matsushima , Federica Sallusto , Antonio Lanzavecchia , Satoshi Ueha , Toshihiro Ito , Paul G. Thomas doi: https://doi.org/10.64898/2026.11.12.763997 Hiroyasu Aoki 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hiroyasu Aoki Mikhail V. Pogorelyy 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Philip Bradley 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cecilia Adragna 2 Institute for Research in Biomedicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stefan A. Schattgen 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anastasia A. Minervina 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Koshlan Harlan Mayer-Blackwell 3 Fred Hutchinson Cancer Research Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Koshlan Harlan Mayer-Blackwell Kasi Vegesana 4 St. Jude Children's Research Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Zachary B. Scott 4 St. Jude Children's Research Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Velmurugan Balaraman 4 St. Jude Children's Research Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site E. Kaitlynn Allen 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Masahiro Kitabatake 5 Nara Medical University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Noriko Ouji-Sageshima 5 Nara Medical University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Atsushi Hara 5 Nara Medical University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Peng Xu 6 Tokyo University of Science; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Chihiro Motozono 7 Kumamoto University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kouji Matsushima 6 Tokyo University of Science; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Federica Sallusto 2 Institute for Research in Biomedicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Antonio Lanzavecchia 8 National Institute of Molecular Genetics Find this author on Google Scholar Find this author on PubMed Search for this author on this site Satoshi Ueha 6 Tokyo University of Science; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: ueha{at}rs.tus.ac.jp Toshihiro Ito 5 Nara Medical University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Paul G. Thomas 1 Fred Hutchinson Cancer Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Preview PDF Abstract Defining the dynamics of T cell memory formation with epitope-level resolution can inform vaccine design. Longitudinal T cell receptor (TCR) sequencing after COVID-19 mRNA vaccination has enabled detailed tracking of T cell responses; however, connecting expanded clonotypes following antigen exposure to their cognate epitopes remains a challenge due to limited curated paired α/βTCR information. To fill this gap, we used TIRTL-seq to identify paired α/βTCRs from CD8+ T cell lineages associated with mRNA immunization in serial samples across 38 healthy donors over multiple rounds of vaccinations. Vaccine-associated paired α/βTCRs, identified based on their longitudinal kinetics, were grouped according to sequence similarity to infer their shared epitope specificities. We assigned epitope specificity to 1,109 clonotypes, recognizing 15 SARS-CoV-2 spike targets, identifying multiple previously undescribed responses, and confirming putative specificities experimentally. This approach uncovered a striking pattern of clonal succession in anti-spike T cell memory lineages resulting from repeated vaccination, characterized by a transition from low-avidity clones recognizing conserved coronavirus epitopes to high-avidity clones targeting epitopes unique to SARS-CoV-2. These results highlight the surprisingly dynamic responses underlying homologous boosting, suggest avenues for improving vaccine strategies, and pave the way for repertoire-based monitoring of antigen-specific T cell immunity. Competing Interest Statement P.G.T. is on the Scientific Advisory Board of Immunoscape and Shennon Bio, has received research support and personal fees from Elevate Bio, and consulted for 10X Genomics, Illumina, Pfizer, Cytoagents, Sanofi, Merck, and JNJ. P.G.T., M.V.P., and A.A.M. have patents related to TCR amplification, cloning and/or applications thereof. P.X. is currently a full-time employee of ImmunoGeneTeqs, Inc. T.I. reports research funding from Rohto Pharmaceutical Co., Ltd and Biometrics Sympathies Inc. K.M. reports stock for ImmunoGeneTeqs, Inc. S.U. reports an advisory role for ImmunoGeneTeqs, Inc. and stock for ImmunoGeneTeqs, Inc. The other authors declare no competing interests. Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88 , R01 AI136514 , U19 AI181103 , P01 AI165077 , R35 GM141457 St. Jude Center for Influenza Research and Response (SJCEIRR) , 75N93021C0016 Center for Influenza Vaccine Research in High Risk Populations (CIVR-HRP) , 75N93019C00052 Cancer Research Institute Irvington Postdoctoral Fellowship , CRI14316 Japan Agency for Medical Research and Development, https://ror.org/004rtk039 , JP256f0137011 , JP22fk0310509 , JP25fk0310531 , JP26ck0106121 Japan Society for the Promotion of Science, https://ror.org/00hhkn466 , JPJS00420240025 , JP23K27397 , JP26K02239 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted November 13, 2026. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession Hiroyasu Aoki , Mikhail V. Pogorelyy , Philip Bradley , Cecilia Adragna , Stefan A. Schattgen , Anastasia A. Minervina , Koshlan Harlan Mayer-Blackwell , Kasi Vegesana , Zachary B. Scott , Velmurugan Balaraman , E. Kaitlynn Allen , Masahiro Kitabatake , Noriko Ouji-Sageshima , Atsushi Hara , Peng Xu , Chihiro Motozono , Kouji Matsushima , Federica Sallusto , Antonio Lanzavecchia , Satoshi Ueha , Toshihiro Ito , Paul G. Thomas bioRxiv 2026.11.12.763997; doi: https://doi.org/10.64898/2026.11.12.763997 Share This Article: Copy Citation Tools Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession Hiroyasu Aoki , Mikhail V. Pogorelyy , Philip Bradley , Cecilia Adragna , Stefan A. Schattgen , Anastasia A. Minervina , Koshlan Harlan Mayer-Blackwell , Kasi Vegesana , Zachary B. Scott , Velmurugan Balaraman , E. Kaitlynn Allen , Masahiro Kitabatake , Noriko Ouji-Sageshima , Atsushi Hara , Peng Xu , Chihiro Motozono , Kouji Matsushima , Federica Sallusto , Antonio Lanzavecchia , Satoshi Ueha , Toshihiro Ito , Paul G. Thomas bioRxiv 2026.11.12.763997; doi: https://doi.org/10.64898/2026.11.12.763997 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Animal Behavior and Cognition (8164) Biochemistry (19027) Bioengineering (15171) Bioinformatics (45975) Biophysics (22958) Cancer Biology (20299) Cell Biology (27561) Clinical Trials (138) Developmental Biology (14274) Ecology (21588) Epidemiology (2067) Evolutionary Biology (25993) Genetics (16461) Genomics (24046) Immunology (19232) Microbiology (43597) Molecular Biology (18537) Neuroscience (96102) Paleontology (718) Pathology (3074) Pharmacology and Toxicology (5265) Physiology (8362) Plant Biology (16431) Scientific Communication and Education (2124) Synthetic Biology (4688) Systems Biology (10473) Zoology (2440)
## Related Clinical Research

- [Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses](https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine.md)
- [Distinct Maturation-Associated Neutrophil Transcriptional Programs in COVID-19 Versus Tuberculosis](https://medichelpline.com/clinical-feed/biorxiv-2-covid-19-and-active-tuberculosis-exhibit-distinct-maturation-associated.md)
- [Influenza Vaccination Associated with Lower IMV and Death Risk in Older Hospitalized Adults — Fran](https://medichelpline.com/clinical-feed/medrxiv-3-influenza-vaccination-and-disease-severity-among-older-adults-hospitalized-with.md)
- [Epidemiology of acute respiratory infections in adults at Hospices Civils de Lyon (2016–2025)](https://medichelpline.com/clinical-feed/medrxiv-7-epidemiology-of-acute-respiratory-infections-in-adult-patients-in-hospices.md)
- [Washington resident dies after exposure to H5N1-infected dairy cattle](https://medichelpline.com/clinical-feed/stat-news-0-washington-state-resident-dies-from-bird-flu-following-exposure-to-infected.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.